A carregar...

BRCA1 protein levels and PIK3CA mutations as predictive biomarkers for response to neoadjuvant chemotherapy in locally advanced breast cancer: An exploratory analysis

BRCA1 overexpression and phosphoinositide 3-kinase (PIK3CA) pathway activation are involved in the resistance to DNA damaging agents. Thus, we hypothesized that BRCA1 protein expression and activating PIK3CA mutations are potential tumor biomarkers for the chemotherapeutic response to doxorubicin/cy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: HILTON, J., WEBERPALS, J., LORIMER, I., AMIN, S., ISLAM, S., PELLETIER, L., DANESHMAND, M., HANSON, J., NABAVI, M., PAROLIN, D., MALLICK, R., VERMA, S.
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3398358/
https://ncbi.nlm.nih.gov/pubmed/22807977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2012.697
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!